Proadrenomedullin as a prognostic marker in neonatal sepsis

Creative Commons License

Oncel M. Y. , Dilmen U., ERDEVE Ö., Ozdemir R., Calisici E., Yurttutan S., ...More

PEDIATRIC RESEARCH, vol.72, no.5, pp.507-512, 2012 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 72 Issue: 5
  • Publication Date: 2012
  • Doi Number: 10.1038/pr.2012.106
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.507-512


BACKGROUND: Proadrenomedullin (pro-ADM) for the diagnosis of proven and clinical sepsis in a newborn cohort including preterm newborns has not been investigated. We aimed to investigate the value of pro-ADM as a new marker by comparing it with conventional markers in neonatal sepsis (NS).